Table of Content

1. Product Overview
2. Research Methodology
3. Impact of COVID-19 on Global Central Nervous System Therapeutics Market
4. Executive Summary
5. Voice of Customer
5.1. Factors Driving Global Central Nervous System Therapeutics Market
5.2. Factors Influencing Purchase Decision of Central Nervous System Drugs
5.3. Brand Awareness
6. Global Central Nervous System Therapeutics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Drug Class (Multiple Sclerosis, Antipsychotic, Antiepileptics, Analgesics & Anesthetics, Anti-Parkinson, Others)
6.2.2. By Application (Neurodegenerative Diseases, Mental Health and Trauma, Neurovascular Diseases, Infectious Diseases, CNS Cancer, Others)
6.2.3. By Route of Administration (Oral, Parenteral, Others)
6.2.4. By End User (Hospital, Clinics, Diagnostic Laboratories, Others)
6.2.5. By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
6.2.6. By Company (2020)
6.2.7. By Region (North America, Europe, Asia-Pacific, South America, Middle East & Africa)
6.3. Market Map
7. North America Central Nervous System Therapeutics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Drug Class
7.2.2. By Application
7.2.3. By Route of Administration
7.2.4. By End User
7.2.5. By Distribution Channel
7.2.6. By Country (United States; Canada; Mexico)
7.3. North America: Country Analysis
7.3.1. United States Central Nervous System Therapeutics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Drug Class
7.3.1.2.2. By Application
7.3.1.2.3. By Route of Administration
7.3.1.2.4. By End User
7.3.1.2.5. By Distribution Channel
7.3.2. Canada Central Nervous System Therapeutics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Drug Class
7.3.2.2.2. By Application
7.3.2.2.3. By Route of Administration
7.3.2.2.4. By End User
7.3.2.2.5. By Distribution Channel
7.3.3. Mexico Central Nervous System Therapeutics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Drug Class
7.3.3.2.2. By Application
7.3.3.2.3. By Route of Administration
7.3.3.2.4. By End User
7.3.3.2.5. By Distribution Channel
8. Europe Central Nervous System Therapeutics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Drug Class
8.2.2. By Application
8.2.3. By Route of Administration
8.2.4. By End User
8.2.5. By Distribution Channel
8.2.6. By Country (Germany; France; United Kingdom; Italy; Spain)
8.3. Europe: Country Analysis
8.3.1. Germany Central Nervous System Therapeutics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Drug Class
8.3.1.2.2. By Application
8.3.1.2.3. By Route of Administration
8.3.1.2.4. By End User
8.3.1.2.5. By Distribution Channel
8.3.2. France Central Nervous System Therapeutics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Drug Class
8.3.2.2.2. By Application
8.3.2.2.3. By Route of Administration
8.3.2.2.4. By End User
8.3.2.2.5. By Distribution Channel
8.3.3. United Kingdom Central Nervous System Therapeutics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Drug Class
8.3.3.2.2. By Application
8.3.3.2.3. By Route of Administration
8.3.3.2.4. By End User
8.3.3.2.5. By Distribution Channel
8.3.4. Italy Central Nervous System Therapeutics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Drug Class
8.3.4.2.2. By Application
8.3.4.2.3. By Route of Administration
8.3.4.2.4. By End User
8.3.4.2.5. By Distribution Channel
8.3.5. Spain Central Nervous System Therapeutics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Drug Class
8.3.5.2.2. By Application
8.3.5.2.3. By Route of Administration
8.3.5.2.4. By End User
8.3.5.2.5. By Distribution Channel
9. APAC Central Nervous System Therapeutics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Drug Class
9.2.2. By Application
9.2.3. By Route of Administration
9.2.4. By End User
9.2.5. By Distribution Channel
9.2.6. By Country (China; Japan; India; South Korea; Australia)
9.3. APAC: Country Analysis
9.3.1. China Central Nervous System Therapeutics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Drug Class
9.3.1.2.2. By Application
9.3.1.2.3. By Route of Administration
9.3.1.2.4. By End User
9.3.1.2.5. By Distribution Channel
9.3.2. Japan Central Nervous System Therapeutics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Drug Class
9.3.2.2.2. By Application
9.3.2.2.3. By Route of Administration
9.3.2.2.4. By End User
9.3.2.2.5. By Distribution Channel
9.3.3. India Central Nervous System Therapeutics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Drug Class
9.3.3.2.2. By Application
9.3.3.2.3. By Route of Administration
9.3.3.2.4. By End User
9.3.3.2.5. By Distribution Channel
9.3.4. South Korea Central Nervous System Therapeutics Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Drug Class
9.3.4.2.2. By Application
9.3.4.2.3. By Route of Administration
9.3.4.2.4. By End User
9.3.4.2.5. By Distribution Channel
9.3.5. Australia Central Nervous System Therapeutics Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Drug Class
9.3.5.2.2. By Application
9.3.5.2.3. By Route of Administration
9.3.5.2.4. By End User
9.3.5.2.5. By Distribution Channel
10. South America Central Nervous System Therapeutics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Drug Class
10.2.2. By Application
10.2.3. By Route of Administration
10.2.4. By End User
10.2.5. By Distribution Channel
10.2.6. By Country (Brazil; Argentina; Colombia)
10.3. South America: Country Analysis
10.3.1. Brazil Central Nervous System Therapeutics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Drug Class
10.3.1.2.2. By Application
10.3.1.2.3. By Route of Administration
10.3.1.2.4. By End User
10.3.1.2.5. By Distribution Channel
10.3.2. Argentina Central Nervous System Therapeutics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Drug Class
10.3.2.2.2. By Application
10.3.2.2.3. By Route of Administration
10.3.2.2.4. By End User
10.3.2.2.5. By Distribution Channel
10.3.3. Colombia Central Nervous System Therapeutics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Drug Class
10.3.3.2.3. By Application
10.3.3.2.4. By Route of Administration
10.3.3.2.5. By End User
10.3.3.2.6. By Distribution Channel
11. MEA Central Nervous System Therapeutics Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Drug Class
11.2.2. By Application
11.2.3. By Route of Administration
11.2.4. By End User
11.2.5. By Distribution Channel
11.2.6. By Country (South Africa; Saudi Arabia; UAE)
11.3. MEA: Country Analysis
11.3.1. South Africa Central Nervous System Therapeutics Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Drug Class
11.3.1.2.2. By Application
11.3.1.2.3. By Route of Administration
11.3.1.2.4. By End User
11.3.1.2.5. By Distribution Channel
11.3.2. Saudi Arabia Central Nervous System Therapeutics Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Drug Class
11.3.2.2.2. By Application
11.3.2.2.3. By Route of Administration
11.3.2.2.4. By End User
11.3.2.2.5. By Distribution Channel
11.3.3. UAE Central Nervous System Therapeutics Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Drug Class
11.3.3.2.2. By Application
11.3.3.2.3. By Route of Administration
11.3.3.2.4. By End User
11.3.3.2.5. By Distribution Channel
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape
14.1. Competition Outlook
14.2. Global Players Profiled (Leading Companies)
14.2.1. Biogen Inc.
14.2.2. Johnson & Johnson
14.2.3. F. Hoffmann-La Roche AG
14.2.4. Novartis AG
14.2.5. Sanofi AG
14.2.6. Eli Lilly and Company Ltd.
14.2.7. Pfizer Inc.
14.2.8. Merck & Co. Inc.
14.2.9. AstraZeneca PLC
14.2.10. Teva Pharmaceutical Industries Ltd.
14.2.11. GlaxoSmithKline PLC
14.2.12. Bayer AG
14.2.13. Otsuka Holdings Co. Ltd.
14.2.14. Amgen Inc.
14.2.15. Bristol Myers Squibb Pharmaceuticals Ltd.
15. Strategic Recommendations
16. About Us & Disclaimer



List of Figures

Figure 1: Global Central Nervous System Therapeutics Market Size, By Value (USD Million), 2016-2026F
Figure 2: Global Central Nervous System Therapeutics Market Share, By Drug Class Type, By Value, 2016-2026F
Figure 3: Global Central Nervous System Therapeutics Market Share, By Application, By Value, 2016-2026F
Figure 4: Global Central Nervous System Therapeutics Market Share, By Route of Administration, By Value, 2016-2026F
Figure 5: Global Central Nervous System Therapeutics Market Share, By End User, By Value, 2016-2026F
Figure 6: Global Central Nervous System Therapeutics Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 7: Global Central Nervous System Therapeutics Market Share, By Company, 2016-2026F
Figure 8: Global Central Nervous System Therapeutics Market Share, By Region, By Value, 2016-2026F
Figure 9: Global Central Nervous System Therapeutics Market Size, Market Map, By Value, 2016-2026F
Figure 10: North America Central Nervous System Therapeutics Market Size, By Value (USD Million), 2016-2026F
Figure 11: North America Central Nervous System Therapeutics Market Share, By Drug Class Type, By Value, 2016-2026F
Figure 12: North America Central Nervous System Therapeutics Market Share, By Route of Administration, By Value, 2016-2026F
Figure 13: North America Central Nervous System Therapeutics Market Share, By Application, By Value, 2016-2026F
Figure 14: North America Central Nervous System Therapeutics Market Share, By End User, By Value, 2016-2026F
Figure 15: North America Central Nervous System Therapeutics Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 16: North America Central Nervous System Therapeutics Market Share, By Country, By Value, 2016-2026F
Figure 17: United States Central Nervous System Therapeutics Market Size, By Value (USD Million), 2016-2026F
Figure 18: United States Central Nervous System Therapeutics Market Share, By Drug Class Type, By Value, 2016-2026F
Figure 19: United States Central Nervous System Therapeutics Market Share, By Route of Administration, By Value, 2016-2026F
Figure 20: United States Central Nervous System Therapeutics Market Share, By Application, By Value, 2016-2026F
Figure 21: United States Central Nervous System Therapeutics Market Share, By End User, By Value, 2016-2026F
Figure 22: United States Central Nervous System Therapeutics Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 23: Canada Central Nervous System Therapeutics Market Size, By Value (USD Million), 2016-2026F
Figure 24: Canada Central Nervous System Therapeutics Market Share, By Drug Class Type, By Value, 2016-2026F
Figure 25: Canada Central Nervous System Therapeutics Market Share, By Route of Administration, By Value, 2016-2026F
Figure 26: Canada Central Nervous System Therapeutics Market Share, By Application, By Value, 2016-2026F
Figure 27: Canada Central Nervous System Therapeutics Market Share, By End User, By Value, 2016-2026F
Figure 28: Canada Central Nervous System Therapeutics Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 29: Mexico Central Nervous System Therapeutics Market Size, By Value (USD Million), 2016-2026F
Figure 30: Mexico Central Nervous System Therapeutics Market Share, By Drug Class Type, By Value, 2016-2026F
Figure 31: Mexico Central Nervous System Therapeutics Market Share, By Route of Administration, By Value, 2016-2026F
Figure 32: Mexico Central Nervous System Therapeutics Market Share, By Application, By Value, 2016-2026F
Figure 33: Mexico Central Nervous System Therapeutics Market Share, By End User, By Value, 2016-2026F
Figure 34: Mexico Central Nervous System Therapeutics Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 35: Europe Central Nervous System Therapeutics Market Size, By Value (USD Million), 2016-2026F
Figure 36: Europe Central Nervous System Therapeutics Market Share, By Drug Class Type, By Value, 2016-2026F
Figure 37: Europe Central Nervous System Therapeutics Market Share, By Route of Administration, By Value, 2016-2026F
Figure 38: Europe Central Nervous System Therapeutics Market Share, By Application, By Value, 2016-2026F
Figure 39: Europe Central Nervous System Therapeutics Market Share, By End User, By Value, 2016-2026F
Figure 40: Europe Central Nervous System Therapeutics Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 41: Europe Central Nervous System Therapeutics Market Share, By Country, By Value, 2016-2026F
Figure 42: Germany Central Nervous System Therapeutics Market Size, By Value (USD Million), 2016-2026F
Figure 43: Germany Central Nervous System Therapeutics Market Share, By Drug Class Type, By Value, 2016-2026F
Figure 44: Germany Central Nervous System Therapeutics Market Share, By Route of Administration, By Value, 2016-2026F
Figure 45: Germany Central Nervous System Therapeutics Market Share, By Application, By Value, 2016-2026F
Figure 46: Germany Central Nervous System Therapeutics Market Share, By End User, By Value, 2016-2026F
Figure 47: Germany Central Nervous System Therapeutics Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 48: France Central Nervous System Therapeutics Market Size, By Value (USD Million), 2016-2026F
Figure 49: France Central Nervous System Therapeutics Market Share, By Drug Class Type, By Value, 2016-2026F
Figure 50: France Central Nervous System Therapeutics Market Share, By Route of Administration, By Value, 2016-2026F
Figure 51: France Central Nervous System Therapeutics Market Share, By Application, By Value, 2016-2026F
Figure 52: France Central Nervous System Therapeutics Market Share, By End User, By Value, 2016-2026F
Figure 53: France Central Nervous System Therapeutics Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 54: United Kingdom Central Nervous System Therapeutics Market Size, By Value (USD Million), 2016-2026F
Figure 55: United Kingdom Central Nervous System Therapeutics Market Share, By Drug Class Type, By Value, 2016-2026F
Figure 56: United Kingdom Central Nervous System Therapeutics Market Share, By Route of Administration, By Value, 2016-2026F
Figure 57: United Kingdom Central Nervous System Therapeutics Market Share, By Application, By Value, 2016-2026F
Figure 58: United Kingdom Central Nervous System Therapeutics Market Share, By End User, By Value, 2016-2026F
Figure 59: United Kingdom Central Nervous System Therapeutics Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 60: Italy Central Nervous System Therapeutics Market Size, By Value (USD Million), 2016-2026F
Figure 61: Italy Central Nervous System Therapeutics Market Share, By Drug Class Type, By Value, 2016-2026F
Figure 62: Italy Central Nervous System Therapeutics Market Share, By Route of Administration, By Value, 2016-2026F
Figure 63: Italy Central Nervous System Therapeutics Market Share, By Application, By Value, 2016-2026F
Figure 64: Italy Central Nervous System Therapeutics Market Share, By End User, By Value, 2016-2026F
Figure 65: Italy Central Nervous System Therapeutics Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 66: Spain Central Nervous System Therapeutics Market Size, By Value (USD Million), 2016-2026F
Figure 67: Spain Central Nervous System Therapeutics Market Share, By Drug Class Type, By Value, 2016-2026F
Figure 68: Spain Central Nervous System Therapeutics Market Share, By Route of Administration, By Value, 2016-2026F
Figure 69: Spain Central Nervous System Therapeutics Market Share, By Application, By Value, 2016-2026F
Figure 70: Spain Central Nervous System Therapeutics Market Share, By End User, By Value, 2016-2026F
Figure 71: Spain Central Nervous System Therapeutics Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 72: APAC Central Nervous System Therapeutics Market Size, By Value (USD Million), 2016-2026F
Figure 73: APAC Central Nervous System Therapeutics Market Share, By Drug Class Type, By Value, 2016-2026F
Figure 74: APAC Central Nervous System Therapeutics Market Share, By Route of Administration, By Value, 2016-2026F
Figure 75: APAC Central Nervous System Therapeutics Market Share, By Application, By Value, 2016-2026F
Figure 76: APAC Central Nervous System Therapeutics Market Share, By End User, By Value, 2016-2026F
Figure 77: APAC Central Nervous System Therapeutics Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 78: APAC Central Nervous System Therapeutics Market Share, By Country, By Value, 2016-2026F
Figure 79: China Central Nervous System Therapeutics Market Size, By Value (USD Million), 2016-2026F
Figure 80: China Central Nervous System Therapeutics Market Share, By Drug Class Type, By Value, 2016-2026F
Figure 81: China Central Nervous System Therapeutics Market Share, By Route of Administration, By Value, 2016-2026F
Figure 82: China Central Nervous System Therapeutics Market Share, By Application, By Value, 2016-2026F
Figure 83: China Central Nervous System Therapeutics Market Share, By End User, By Value, 2016-2026F
Figure 84: China Central Nervous System Therapeutics Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 85: Japan Central Nervous System Therapeutics Market Size, By Value (USD Million), 2016-2026F
Figure 86: Japan Central Nervous System Therapeutics Market Share, By Drug Class Type, By Value, 2016-2026F
Figure 87: Japan Central Nervous System Therapeutics Market Share, By Route of Administration, By Value, 2016-2026F
Figure 88: Japan Central Nervous System Therapeutics Market Share, By Application, By Value, 2016-2026F
Figure 89: Japan Central Nervous System Therapeutics Market Share, By End User, By Value, 2016-2026F
Figure 90: Japan Central Nervous System Therapeutics Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 91: India Central Nervous System Therapeutics Market Size, By Value (USD Million), 2016-2026F
Figure 92: India Central Nervous System Therapeutics Market Share, By Drug Class Type, By Value, 2016-2026F
Figure 93: India Central Nervous System Therapeutics Market Share, By Route of Administration, By Value, 2016-2026F
Figure 94: India Central Nervous System Therapeutics Market Share, By Application, By Value, 2016-2026F
Figure 95: India Central Nervous System Therapeutics Market Share, By End User, By Value, 2016-2026F
Figure 96: India Central Nervous System Therapeutics Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 97: South Korea Central Nervous System Therapeutics Market Size, By Value (USD Million), 2016-2026F
Figure 98: South Korea Central Nervous System Therapeutics Market Share, By Drug Class Type, By Value, 2016-2026F
Figure 99: South Korea Central Nervous System Therapeutics Market Share, By Route of Administration, By Value, 2016-2026F
Figure 100: South Korea Central Nervous System Therapeutics Market Share, By Application, By Value, 2016-2026F
Figure 101: South Korea Central Nervous System Therapeutics Market Share, By End User, By Value, 2016-2026F
Figure 102: South Korea Central Nervous System Therapeutics Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 103: Australia Central Nervous System Therapeutics Market Size, By Value (USD Million), 2016-2026F
Figure 104: Australia Central Nervous System Therapeutics Market Share, By Drug Class Type, By Value, 2016-2026F
Figure 105: Australia Central Nervous System Therapeutics Market Share, By Route of Administration, By Value, 2016-2026F
Figure 106: Australia Central Nervous System Therapeutics Market Share, By Application, By Value, 2016-2026F
Figure 107: Australia Central Nervous System Therapeutics Market Share, By End User, By Value, 2016-2026F
Figure 108: Australia Central Nervous System Therapeutics Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 109: South America Central Nervous System Therapeutics Market Size, By Value (USD Million), 2016-2026F
Figure 110: South America Central Nervous System Therapeutics Market Share, By Drug Class Type, By Value, 2016-2026F
Figure 111: South America Central Nervous System Therapeutics Market Share, By Route of Administration, By Value, 2016-2026F
Figure 112: South America Central Nervous System Therapeutics Market Share, By Application, By Value, 2016-2026F
Figure 113: South America Central Nervous System Therapeutics Market Share, By End User, By Value, 2016-2026F
Figure 114: South America Central Nervous System Therapeutics Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 115: South America Central Nervous System Therapeutics Market Share, By Country, By Value, 2016-2026F
Figure 116: Brazil Central Nervous System Therapeutics Market Size, By Value (USD Million), 2016-2026F
Figure 117: Brazil Central Nervous System Therapeutics Market Share, By Drug Class Type, By Value, 2016-2026F
Figure 118: Brazil Central Nervous System Therapeutics Market Share, By Route of Administration, By Value, 2016-2026F
Figure 119: Brazil Central Nervous System Therapeutics Market Share, By Application, By Value, 2016-2026F
Figure 120: Brazil Central Nervous System Therapeutics Market Share, By End User, By Value, 2016-2026F
Figure 121: Brazil Central Nervous System Therapeutics Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 122: Argentina Central Nervous System Therapeutics Market Size, By Value (USD Million), 2016-2026F
Figure 123: Argentina Central Nervous System Therapeutics Market Share, By Drug Class Type, By Value, 2016-2026F
Figure 124: Argentina Central Nervous System Therapeutics Market Share, By Route of Administration, By Value, 2016-2026F
Figure 125: Argentina Central Nervous System Therapeutics Market Share, By Application, By Value, 2016-2026F
Figure 126: Argentina Central Nervous System Therapeutics Market Share, By End User, By Value, 2016-2026F
Figure 127: Argentina Central Nervous System Therapeutics Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 128: Colombia Central Nervous System Therapeutics Market Size, By Value (USD Million), 2016-2026F
Figure 129: Colombia Central Nervous System Therapeutics Market Share, By Drug Class Type, By Value, 2016-2026F
Figure 130: Colombia Central Nervous System Therapeutics Market Share, By Route of Administration, By Value, 2016-2026F
Figure 131: Colombia Central Nervous System Therapeutics Market Share, By Application, By Value, 2016-2026F
Figure 132: Colombia Central Nervous System Therapeutics Market Share, By End User, By Value, 2016-2026F
Figure 133: Colombia Central Nervous System Therapeutics Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 134: MEA Central Nervous System Therapeutics Market Size, By Value (USD Million), 2016-2026F
Figure 135: MEA Central Nervous System Therapeutics Market Share, By Drug Class Type, By Value, 2016-2026F
Figure 136: MEA Central Nervous System Therapeutics Market Share, By Route of Administration, By Value, 2016-2026F
Figure 137: MEA Central Nervous System Therapeutics Market Share, By Application, By Value, 2016-2026F
Figure 138: MEA Central Nervous System Therapeutics Market Share, By End User, By Value, 2016-2026F
Figure 139: MEA Central Nervous System Therapeutics Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 140: MEA Central Nervous System Therapeutics Market Share, By Country, By Value, 2016-2026F
Figure 141: South Africa Central Nervous System Therapeutics Market Size, By Value (USD Million), 2016-2026F
Figure 142: South Africa Central Nervous System Therapeutics Market Share, By Drug Class Type, By Value, 2016-2026F
Figure 143: South Africa Central Nervous System Therapeutics Market Share, By Route of Administration, By Value, 2016-2026F
Figure 144: South Africa Central Nervous System Therapeutics Market Share, By Application, By Value, 2016-2026F
Figure 145: South Africa Central Nervous System Therapeutics Market Share, By End User, By Value, 2016-2026F
Figure 146: South Africa Central Nervous System Therapeutics Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 147: Saudi Arabia Central Nervous System Therapeutics Market Size, By Value (USD Million), 2016-2026F
Figure 148: Saudi Arabia Central Nervous System Therapeutics Market Share, By Drug Class Type, By Value, 2016-2026F
Figure 149: Saudi Arabia Central Nervous System Therapeutics Market Share, By Route of Administration, By Value, 2016-2026F
Figure 150: Saudi Arabia Central Nervous System Therapeutics Market Share, By Application, By Value, 2016-2026F
Figure 151: Saudi Arabia Central Nervous System Therapeutics Market Share, By End User, By Value, 2016-2026F
Figure 152: Saudi Arabia Central Nervous System Therapeutics Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 153: UAE Central Nervous System Therapeutics Market Size, By Value (USD Million), 2016-2026F
Figure 154: UAE Central Nervous System Therapeutics Market Share, By Drug Class Type, By Value, 2016-2026F
Figure 155: UAE Central Nervous System Therapeutics Market Share, By Route of Administration, By Value, 2016-2026F
Figure 156: UAE Central Nervous System Therapeutics Market Share, By Application, By Value, 2016-2026F
Figure 157: UAE Central Nervous System Therapeutics Market Share, By End User, By Value, 2016-2026F
Figure 158: UAE Central Nervous System Therapeutics Market Share, By Distribution Channel, By Value, 2016-2026F